Brief: Neuren Pharmaceuticals Comments On Media Speculation
20/11/2023 01:13
Nov 20 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* COMMENT ON MEDIA SPECULATION
* CLARIFIES APPOINTED A CORPORATE AND STRATEGIC ADVISER
SEVERAL
MONTHS AGO
* CLARIFIES CORPORATE AND STRATEGIC ADVISER APPOINTMENT NOT
IN
RESPONSE TO APPROACHES FROM THIRD PARTIES
Source text for Eikon: ID:nASX1l9MZm
Further company coverage: NEU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuren Pharmaceuticals
See all newsAustralia's Neuren set for weekly gain on FDA nod, drug forecast upgrade
Australia's Neuren Pharmaceuticals gains on upbeat FY trofinetide earnings outlook
Australia's Neuren Pharma rises as US FDA grants orphan tag for NNZ-2591
Strong partner sales propel Neuren Pharmaceuticals to top of Australia benchmark
Brief: Neuren Pharmaceuticals Says DAYBU Recommended For Approval In European Union